Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125743441 | 12574344 | 1 | I | 2016 | 20160711 | 20160720 | 20160720 | EXP | GB-SYMPLMED PHARMACEUTICALS-2016SYMPLMED000267 | SYMPLMED PHARMACEUTICALS | 0.00 | Y | 0.00000 | 20160720 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125743441 | 12574344 | 1 | PS | PERINDOPRIL ERBUMINE. | PERINDOPRIL ERBUMINE | 1 | Oral | 4 MG, QD | Y | U | UNKNOWN | 20184 | 4 | MG | TABLET | ||||
| 125743441 | 12574344 | 2 | SS | ASPIRIN /00002701/ | ASPIRIN | 1 | Oral | UNK | Y | U | UNKNOWN | 0 | |||||||
| 125743441 | 12574344 | 3 | C | ACCRETE D3 | 2 | Oral | 1 DF, BID | U | UNKNOWN | 0 | 1 | DF | |||||||
| 125743441 | 12574344 | 4 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, QD | U | UNKNOWN | 0 | 100 | MG | ||||||
| 125743441 | 12574344 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | U | UNKNOWN | 0 | 5 | MG | ||||||
| 125743441 | 12574344 | 6 | C | DIHYDROCODEINE | DIHYDROCODEINE | 1 | Oral | 30 MG, PRN | U | UNKNOWN | 0 | 30 | MG | ||||||
| 125743441 | 12574344 | 7 | C | DOCUSATE | DOCUSATE | 1 | Oral | 100 MG, BID | U | UNKNOWN | 0 | 100 | MG | ||||||
| 125743441 | 12574344 | 8 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 15 MG, BID | U | UNKNOWN | 0 | 15 | MG | ||||||
| 125743441 | 12574344 | 9 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Oral | 13.7 G, UNK | U | UNKNOWN | 0 | 13.7 | G | ||||||
| 125743441 | 12574344 | 10 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | UNK, PRN | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125743441 | 12574344 | 1 | Product used for unknown indication |
| 125743441 | 12574344 | 2 | Product used for unknown indication |
| 125743441 | 12574344 | 3 | Product used for unknown indication |
| 125743441 | 12574344 | 4 | Product used for unknown indication |
| 125743441 | 12574344 | 5 | Product used for unknown indication |
| 125743441 | 12574344 | 6 | Product used for unknown indication |
| 125743441 | 12574344 | 7 | Product used for unknown indication |
| 125743441 | 12574344 | 8 | Product used for unknown indication |
| 125743441 | 12574344 | 9 | Product used for unknown indication |
| 125743441 | 12574344 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125743441 | 12574344 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125743441 | 12574344 | Abnormal loss of weight | |
| 125743441 | 12574344 | Acute kidney injury | |
| 125743441 | 12574344 | Anaemia | |
| 125743441 | 12574344 | Haematochezia | |
| 125743441 | 12574344 | Haemoglobin decreased | |
| 125743441 | 12574344 | Rash maculo-papular | |
| 125743441 | 12574344 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125743441 | 12574344 | 1 | 20160607 | 0 | ||
| 125743441 | 12574344 | 2 | 20160617 | 0 |